LOS ANGELES — Patients with intracranial aneurysm who respond poorly to the antiplatelet drug clopidogrel when treated with flow diversion using the Pipeline embolization device (Medtronic) have ...
CHICAGO – Among patients with acute coronary syndromes undergoing a procedure such as angioplasty, those who received platelet function tests before receiving antithrombotic therapy to determine ...
The RECLOSE 2–ACS (Responsiveness to Clopidogrel and Stent Thrombosis 2–ACS) trial from Italy provides new information about platelet reactivity but doesn't answer any of the key questions about the ...
The document follows two earlier consensus documents, released in 2013 and 2016. Dominick Angiolillo, MD, PhD (University of Florida College of Medicine – Jacksonville), senior author of the paper, ...
June 6, 2012 (Munich, Germany) — A new substudy of the ISAR-REACT-4 trial has found that those patients with high on-clopidogrel-treatment platelet reactivity (HPR) randomized to bivalirudin (Angiomax ...
Following Stent Placement, Low Platelet Reactivity at Time of Discharge and After 30 Days Leads to 50% Reduction in Cardiovascular Events "These new findings from GRAVITAS demonstrate that patients ...
Modifying a patient's dosage of the antiplatelet drug clopidogrel for 6 months depending on the patient's level of platelet reactivity did not result in combined lower rates of nonfatal heart attack, ...
In patients undergoing peripheral endovascular procedures, high on-treatment platelet reactivity is associated with a dramatic increase in risk of adverse clinical events, according to a study ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results